Hematological Consults in the Neuro-ICU
Join Dr. Camila Masias, a hematology and oncology physician with Miami Cancer Institute, in this discussion on hypercoagulable studies in critically ill patients. We will focus on identifying and managing heparin-induced thrombocytopenia (HIT) as a rare cause of thrombocytopenia.
Adult and Pediatric Neurologists, Neurosurgeons, Stroke Neurologists, Neuroradiologists, Diagnostic Radiologists, Critical Care Physicians, Neurointensivists, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Rehabilitation and Pain Management Specialists, Physician Assistants, Critical Care and Neuroscience Nurses, Neurosurgery Nurses, Nurse Practitioners, as well as other specialists interested in the field of neuroscience.
- Assess when hypercoagulable studies are needed in patients with stroke and implement appropriate follow-up with abnormal hypercoagulable test result.
- Identify and manage heparin-induced thrombocytopenia (HIT) as a rare cause of thrombocytopenia in the critically ill patient.
- Utilize the 4T score in patients with suspected HIT.
Camila Masias, M.D., MPH
Medical Oncologist and Benign Hematologist
Miami Cancer Institute
Baptist Health Quality Network
Baptist Health Medical Group
Baptist Health South Florida
Camila Masias, M.D., MPH, has indicated that she is a consultant with Rigel Pharmaceuticals and she will not include off-label or unapproved product usage in her presentation or discussion.
This online course is a highlight from the 2019 Miami Neuroscience Symposium. The following is the symposium planning committee.
Kevin Abrams, M.D., indicated that he is a consultant for Keystone Heart. He is also a shareholder in Cleerly and Keystone Heart.
Guilherme Dabus, M.D., indicated that he is a consultant for Microvention, Medtronic, Cernovus and Penumbra. He is a proctor for Medtronic. Dr. Dabus is also a shareholder in Surpass Medical/Stryker, InNeuroCo, Medina Medical/Medtronic, eLum, Three Rivers Medical and RIST.
Felipe De Los Rios La Rosa, M.D., indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interests.
Karel Fuentes, M.D., indicated that neither they nor their spouse/partner have relevant financial relationships with commercial interest companies.
Bruno Gallo, M.D., indicated that he is a consultant for Surgimon, Inc. He is on the speakers bureau for Teva, Acadia, Adamas and Sunovion. Dr. Gallo has also received grant/research support from St. Jude Medical and Medtronic.
Italo Linfante, M.D., indicated that he is a consultant for Medtronic and Stryker. Dr. Linfante is also a shareholder in InNeuroCo and Three Rivers Medical.
Alberto Pinzon-Ardila, M.D., PH.D., indicated that he is on the speakers bureau for Sunovion and UCB.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.